Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ealong.cn

Stage

Series A | Alive

About ealong biotech

Provider of biological products. The company provides rabies purified vaccine for human use (vero cell), splitted influenza vaccine, corynebacterium parvum preparation, trachitis vaccine, furunculosis vaccine, and lyophilized epidemic mumps vaccine.

ealong biotech Headquarters Location

878 Zhongwu Avenue

Changzhou, Jiangsu, 213018,

China

86 519 88250088

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is ealong biotech's headquarters?

    ealong biotech's headquarters is located at 878 Zhongwu Avenue, Changzhou.

  • What is ealong biotech's latest funding round?

    ealong biotech's latest funding round is Series A.

  • Who are the investors of ealong biotech?

    Investors of ealong biotech include SIG Asia Investments.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.